Cardiothoracic Surgery
News
Hybrid option ‘reasonable’ for HLHS?
Key clinical point: A hybrid operation for hypoplastic left heart syndrome (HLHS) and variants in neonates is emerging as an alternative to the...
Conference Coverage
Surgeons commonly off the mark in estimating blood loss
MONTREAL – Inaccurate estimations of blood loss during surgery may render EBL inappropriate as a quality measure.
Conference Coverage
Similarities seen in rate and rhythm control for postsurgical AF
Key clinical point: Rate control offers the advantage of simplicity over a rhythm control strategy in new-onset atrial fibrillation after cardiac...
Conference Coverage
VIDEO: STICHES trial update boosts CABG in ischemic cardiomyopathy
Surgery shows significant survival advantage over medical therapy in patients with coronary artery disease and heart failure with severe left...
Conference Coverage
VIDEO: STICHES trial update boosts CABG in ischemic cardiomyopathy
Surgery shows significant survival advantage over medical therapy in patients with coronary artery disease and heart failure with severe left...
News
Risk score predicts rehospitalization after heart surgery
Key clinical point: A risk score predicted which heart surgery patients faced the greatest risk for hospital readmission within 30 days of their...
From the Journals
Wanted: Better evidence on fast-track lung resection
Key clinical point: Well-designed clinical trials are needed to determine the effectiveness of fast-track recovery pathways in lung resection.
News
Serious complications after cancer surgery linked to worse long-term survival
Serious complications after esophageal, lung, and pancreatic cancer resections are common and they are associated with dramatically inferior long-...
Conference Coverage
Periop statins don’t prevent acute kidney injury after cardiac surgery
Key clinical point: Perioperative atorvastatin did not protect against acute kidney injury after cardiac surgery. Major finding: Acute kidney...
From the Journals
NSQIP calculator shown inadequate to stratify risk in stage I non–small cell lung cancer.
Key clinical point: The current NSQIP Surgical Risk Calculator does not adequately estimate risk among patients with clinical stage I non–small...